These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 6362186)

  • 21. Serum beta 2 microglobulin in malignant lymphoproliferative disorders.
    Constantinides IP; Pathouli C; Karvountzis G; Papadopoulos P; Varvoutsi-Constantinides M; Eliakis P; Hadziyannis S; Komninos Z
    Cancer; 1985 May; 55(10):2384-9. PubMed ID: 3886124
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Assay of serum beta 2-microglobulin in patients with malignant hematologic diseases and its clinical significance].
    Zhong M; Liu W
    Hunan Yi Ke Da Xue Xue Bao; 1997; 22(3):277-8. PubMed ID: 9868137
    [No Abstract]   [Full Text] [Related]  

  • 23. Beta 2-microglobulin: a potentially useful marker for hematologic malignancies.
    Garewal H; Durie BG
    Ariz Med; 1981 Dec; 38(12):912-3. PubMed ID: 6174109
    [No Abstract]   [Full Text] [Related]  

  • 24. Culture of lymphocytes stimulated by phytohaemagglutinin (PHA) in presence of lithium in patients with lymphoma.
    Villeneuve B; Villeneuve A; Delage JM
    Int J Clin Pharmacol; 1973 Feb; 7(1):87-8. PubMed ID: 4739734
    [No Abstract]   [Full Text] [Related]  

  • 25. Circulation and emigration kinetics of blood lymphocytes in lymphoma patients.
    Bremer K; Engeset A; Fröland SS
    Lymphology; 1978 Dec; 11(4):231-7. PubMed ID: 310921
    [No Abstract]   [Full Text] [Related]  

  • 26. [Hematological changes in children with neoplasms].
    Ochocka M; Ciepielewska D; Traczewska M
    Pediatr Pol; 1980 Oct; 55(10):1165-71. PubMed ID: 7005853
    [No Abstract]   [Full Text] [Related]  

  • 27. The significance of beta-2 microglobulin in clinical medicine.
    Hoekman K; Van Nieuwkoop JA; Willemze R
    Neth J Med; 1985; 28(12):551-7. PubMed ID: 3911084
    [No Abstract]   [Full Text] [Related]  

  • 28. [Importance of determination of serum beta-2-microglobulin levels in patients with Hodgkin's lymphoma].
    Raida L; Papajík T; Hlusí A; Faber E; Urbanová R; Heczko M; Jancíková M; Zapletalová J; Komenda S; Indrák K
    Vnitr Lek; 2002 Feb; 48(2):91-5. PubMed ID: 11949228
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Lymphocytes in malignant lymphoma and other related diseases].
    Itoga T; Yamamoto H; Kunitake A
    Saishin Igaku; 1969 Aug; 24(8):1672-80. PubMed ID: 5395283
    [No Abstract]   [Full Text] [Related]  

  • 30. Lymphoid nodules of bone marrow: normal and abnormal.
    Rywlin AM; Ortega RS; Dominguez CJ
    Blood; 1974 Mar; 43(3):389-400. PubMed ID: 4130097
    [No Abstract]   [Full Text] [Related]  

  • 31. Alterations of plasma levels in malignant lymphoma.
    Opat P; Rejthar A; Tomanová J; Trnka A; Wotke R
    Neoplasma; 1981; 28(3):339-43. PubMed ID: 7290261
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Beta-2-microglobulin levels in patients with extranodal B-cell lymphoma of the mucosa-associated lymphoid tissue (MALT)-type: a retrospective analysis.
    Penz MZ; Fiebiger WC; Valencak JB; Osterreicher C; Ba-Ssalamah A; Formanek M; Brodowic T; Chott A; Raderer M
    Anticancer Res; 2001; 21(4B):3049-52. PubMed ID: 11712809
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Beta 2 microglobulin in lymphoproliferative status].
    Schaimberg L; Ikeda F; Cordeiro M; Santos RA; Murakami S; Scheinberg MA
    Rev Paul Med; 1987; 105(3):183-4. PubMed ID: 3329760
    [No Abstract]   [Full Text] [Related]  

  • 34. Malignant lymphoma and lymphatic leukemia associated with myeloma-type serum proteins.
    AZAR HA; HILL WT; OSSERMAN EF
    Am J Med; 1957 Aug; 23(2):239-49. PubMed ID: 13444306
    [No Abstract]   [Full Text] [Related]  

  • 35. Serum zinc levels in patients with malignant lymphomas.
    Kolarić K; Roguljić A; Ivanković G; Vukas D
    Acta Med Iugosl; 1975; 29(4):331-8. PubMed ID: 1189979
    [No Abstract]   [Full Text] [Related]  

  • 36. Clinical features of adult T-cell leukemia in Kagoshima, the southernmost district in Japan - comparison with T-cell lymphoma.
    Nomura K; Matsumoto M
    Nihon Ketsueki Gakkai Zasshi; 1981 Dec; 44(7):1444-57. PubMed ID: 6979154
    [No Abstract]   [Full Text] [Related]  

  • 37. The prognostic significance of beta(2)-microglobulin in patients with Hodgkin's lymphoma.
    Vassilakopoulos TP; Nadali G; Angelopoulou MK; Siakantaris MP; Dimopoulou MN; Kontopidou FN; Karkantaris C; Kokoris SI; Kyrtsonis MC; Tsaftaridis P; Pizzolo G; Pangalis GA
    Haematologica; 2002 Jul; 87(7):701-8; discussion 708. PubMed ID: 12091120
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lymphocytic characterization in Hodgkin's and non-Hodgkin's lymphoma.
    Kamthan M; Joshi N; Sharma ML
    Indian J Pathol Microbiol; 1982 Apr; 25(2):139-43. PubMed ID: 6982850
    [No Abstract]   [Full Text] [Related]  

  • 39. [Functional characteristics of thrombocytes of healthy persons and patients with reticuloses, lymphogranulomatosis, chronic lymphatic leukemia].
    Pimenov IuS
    Lab Delo; 1971; 5():294-8. PubMed ID: 4108731
    [No Abstract]   [Full Text] [Related]  

  • 40. [Stability of serum protein-lipid complexes in lymphogranulomatosis and chronic lympholeukemia].
    Sarnitskiĭ IP; Guseva SA
    Vrach Delo; 1981 Apr; (4):96-8. PubMed ID: 7269493
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.